ClearPoint Neuro (CLPT) EPS (Diluted) Growth (3y) (2016 - 2026)
ClearPoint Neuro (CLPT) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.07% |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn | -9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29% |
| Mar 31, 2026 | 10.40% |
| Dec 31, 2025 | -12.58% |
| Sep 30, 2025 | 22.83% |
| Jun 30, 2025 | 30.38% |
| Mar 31, 2025 | 23.19% |
| Dec 31, 2024 | 6.69% |
| Sep 30, 2024 | 40.35% |
| Jun 30, 2024 | 42.66% |
| Mar 31, 2024 | 49.39% |
| Dec 31, 2023 | 47.71% |
| Sep 30, 2023 | 54.28% |
| Jun 30, 2023 | 28.55% |
| Mar 31, 2023 | 30.27% |
| Dec 31, 2022 | 29.13% |
| Sep 30, 2022 | 9.11% |
| Jun 30, 2022 | 9.63% |
| Mar 31, 2022 | 10.76% |
| Dec 31, 2021 | 30.85% |
| Sep 30, 2021 | -3.04% |